Susquehanna International Group, LLP Vaxcyte, Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 152,852 shares of PCVX stock, worth $6.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,852

Previous 318,338 51.98%

Holding current value

$6.47 Million

Previous $12 Million 58.66%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$28.04 - $37.2 $4.64 Million - $6.16 Million	-165,486 Reduced 51.98%	152,852 $4.97 Million
Q1 2025 May 14, 2025	BUY	$37.76 - $92.13 $7.29 Million - $17.8 Million	192,942 Added 153.87%	318,338 $12 Million
Q4 2024 Feb 14, 2025	BUY	$80.97 - $117.93 $6.55 Million - $9.54 Million	80,926 Added 181.98%	125,396 $10.3 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $1.43 Million - $2.38 Million	20,343 Added 84.32%	44,470 $5.08 Million
Q2 2024 Aug 15, 2024	SELL	$60.06 - $78.77 $1.18 Million - $1.55 Million	-19,684 Reduced 44.93%	24,127 $1.82 Million
Q1 2024 May 07, 2024	BUY	$59.79 - $81.05 $784,026 - $1.06 Million	13,113 Added 42.72%	43,811 $2.99 Million
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $407,832 - $570,246	8,993 Added 41.43%	30,698 $1.93 Million
Q3 2023 Nov 14, 2023	SELL	$46.0 - $53.1 $261,464 - $301,820	-5,684 Reduced 20.75%	21,705 $1.11 Million
Q2 2023 Aug 11, 2023	SELL	$34.66 - $54.07 $2.19 Million - $3.42 Million	-63,216 Reduced 69.77%	27,389 $1.37 Million
Q1 2023 May 16, 2023	BUY	$36.27 - $47.2 $2.71 Million - $3.52 Million	74,647 Added 467.77%	90,605 $3.4 Million
Q4 2022 Feb 14, 2023	SELL	$20.58 - $47.95 $565,908 - $1.32 Million	-27,498 Reduced 63.28%	15,958 $765,000
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $420,243 - $552,768	-19,375 Reduced 30.84%	43,456 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $832,215 - $1.25 Million	47,071 Added 298.67%	62,831 $1.37 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $76,544 - $115,562	-4,384 Reduced 21.76%	15,760 $381,000
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $103,902 - $142,248	5,378 Added 36.42%	20,144 $479,000
Q3 2021 Nov 15, 2021	SELL	$20.26 - $26.97 $84,484 - $112,464	-4,170 Reduced 22.02%	14,766 $375,000
Q2 2021 Aug 11, 2021	BUY	$16.45 - $24.06 $311,497 - $455,600	18,936 New	18,936 $426,000

Others Institutions Holding PCVX

# of Institutions

322

Shares Held

139M

Call Options Held

229K

Put Options Held

160K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.51B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Vaxcyte, Inc. Transaction History